Back
SiriusPoint Ltd. 10K Form
Sell
38
SPNT
SiriusPoint Ltd.
Last Price:
$20.91
Seasonality Move:
0.2%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-23 | 10K | SPNT/SiriusPoint Ltd. Annual |
| 2020-11-05 | 10Q | SPNT/SiriusPoint Ltd. Quarterly |
| 2020-08-10 | 10Q | SPNT/SiriusPoint Ltd. Quarterly |
| 2020-05-07 | 10Q | SPNT/SiriusPoint Ltd. Quarterly |
| 2020-02-28 | 10K | SPNT/SiriusPoint Ltd. Annual |
| 2019-11-05 | 10Q | SPNT/SiriusPoint Ltd. Quarterly |
Receive SPNT News And Ratings
See the #1 stock for the next 7 days that we like better than SPNT
SPNT Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $155.1M |
| Price / Cash Flow: | 18.7 |
| Annual Sales: | $19.40 |
| Price / Book: | 1.1 |
Profitability
| EPS (TTM): | 3.68250 |
|---|---|
| Net Income (TTM): | $460.1M |
| Gross Margin: | $0 |
| Return on Equity: | 21.39% |
| Return on Assets: | 4.74% |
SiriusPoint Ltd. Earnings Forecast
Key SiriusPoint Ltd. Financial Ratios
-
The Gross Profit Margin over the past 15 years for SPNT is 0.00%.
-
The Selling, General & Administrative Expenses for SPNT have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 17.32% of Operating Income.
-
The Net Earning history of SPNT is 14.36% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 7 years.
SiriusPoint Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | SPNT |
| Website: | siriuspt.com |
Debt
| Debt-to-Equity Ratio: | 0.28 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 5.88 |
|---|---|
| Forward P/E Ratio: | 7.88 |
SPNT Technical Analysis vs Fundamental Analysis
Sell
38
SiriusPoint Ltd. (SPNT)
is a Sell
Is SiriusPoint Ltd. a Buy or a Sell?
-
SiriusPoint Ltd. stock is rated a SellThe current SiriusPoint Ltd. [SPNT] share price is $21.45. The Score for SPNT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.